BDNF genotype Val66Met interacts with acute plasma BDNF levels to predict fear extinction and recall.


Journal

Behaviour research and therapy
ISSN: 1873-622X
Titre abrégé: Behav Res Ther
Pays: England
ID NLM: 0372477

Informations de publication

Date de publication:
10 2021
Historique:
received: 20 02 2021
revised: 17 06 2021
accepted: 28 07 2021
pubmed: 3 8 2021
medline: 9 11 2021
entrez: 2 8 2021
Statut: ppublish

Résumé

Brain-derived neurotropic factor (BDNF) is a potent regulator of memory processes and is believed to influence the consolidation of fear extinction memories. No previous human study has tested the effect of unstimulated BDNF on fear extinction recall, and no study has tested the association between plasma BDNF levels and psychophysiological responding during an extinction paradigm. We tested the association between fear responses during a 2-day differential conditioning, extinction and extinction recall paradigm and Val66Met genotype in a group of healthy participants (N = 191). There were no group differences during habituation or acquisition. Met allele carriers compared to Val homozygotes displayed higher responses to the CS + compared to the CS- during extinction learning and had higher responding to both the CS+ and CS- during extinction recall. Plasma levels of BDNF protein that were collected in a sub-sample of the group (n = 56) moderated the effect of Met allele presence, such that lower BDNF level was associated with higher skin conductance response in the Met but not Val group to the CS+ during extinction learning and to both the CS+ and CS- during extinction recall. The current results extend previous observations of a Val66Met effect during fear extinction learning to extinction recall and show for the first time that these effects are moderated by plasma BDNF level.

Identifiants

pubmed: 34340176
pii: S0005-7967(21)00141-8
doi: 10.1016/j.brat.2021.103942
pii:
doi:

Substances chimiques

Brain-Derived Neurotrophic Factor 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

103942

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Luke John Ney (LJ)

School of Psychological Sciences, University of Tasmania, Australia. Electronic address: luke.ney@utas.edu.au.

Allison Matthews (A)

School of Psychological Sciences, University of Tasmania, Australia.

Emma Nicholson (E)

School of Psychological Sciences, University of Melbourne, Australia.

Daniel Zuj (D)

Department of Psychology, Swansea University, United Kingdom.

Chia Ming Ken Hsu (CM)

School of Psychological Sciences, University of Tasmania, Australia.

Trevor Steward (T)

School of Psychological Sciences, University of Melbourne, Australia.

Bronwyn Graham (B)

School of Psychology, University of New South Wales, Australia.

Ben Harrison (B)

Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne & Melbourne Health, Australia.

David Nichols (D)

Central Science Laboratory, University of Tasmania, Australia.

Kim Felmingham (K)

School of Psychological Sciences, University of Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH